Recent progress in dendrimer-based nanomedicine development

Arch Pharm Res. 2018 Jun;41(6):571-582. doi: 10.1007/s12272-018-1008-4. Epub 2018 Feb 15.

Abstract

Dendrimers offer well-defined nanoarchitectures with spherical shape, high degree of molecular uniformity, and multiple surface functionalities. Such unique structural properties of dendrimers have created many applications for drug and gene delivery, nanomedicine, diagnostics, and biomedical engineering. Dendrimers are not only capable of delivering drugs or diagnostic agents to desired sites by encapsulating or conjugating them to the periphery, but also have therapeutic efficacy in their own. When compared to traditional polymers for drug delivery, dendrimers have distinct advantages, such as high drug-loading capacity at the surface terminal for conjugation or interior space for encapsulation, size control with well-defined numbers of peripheries, and multivalency for conjugation to drugs, targeting moieties, molecular sensors, and biopolymers. This review focuses on recent applications of dendrimers for the development of dendrimer-based nanomedicines for cancer, inflammation, and viral infection. Although dendrimer-based nanomedicines still face some challenges including scale-up production and well-characterization, several dendrimer-based drug candidates are expected to enter clinical development phase in the near future.

Keywords: Dendrimer; Drug delivery; Nanoarchitecture; Nanomedicine; Nanotechnology.

Publication types

  • Review

MeSH terms

  • Dendrimers / chemistry
  • Dendrimers / therapeutic use*
  • Drug Carriers / chemistry*
  • Drug Design*
  • Humans
  • Nanomedicine / methods*
  • Nanomedicine / trends
  • Neoplasms / drug therapy
  • Virus Diseases / drug therapy

Substances

  • Dendrimers
  • Drug Carriers